Importance of the Evolutionarily Conserved Glycine Residue in the N-terminal Region of Human Cystatin C (Gly-11) for Cysteine Endopeptidase Inhibition

Overview

Journal Biochem J

Specialty Biochemistry

Date 1993 Apr 1

PMID 8471031

Citations 16

Authors

A Hall

H Dalboge

A Grubb

M Abrahamson

Affiliations

Soon will be listed here.

Abstract

Human cystatin C variants in which the evolutionarily conserved Gly-11 residue has been replaced by residues with positively charged (Arg), negatively charged (Glu), bulky hydrophobic (Trp), or small (Ser or Ala) side-chains have been produced by site-directed mutagenesis and expression in Escherichia coli. The five variants were isolated and structurally verified. Their inhibitory properties were compared with those of wild-type recombinant cystatin C by determination of the equilibrium constants for dissociation (Ki) of their complexes with the cysteine endopeptidases papain and human cathepsin B and with the cysteine exopeptidase dipeptidyl peptidase I. The Ser-11 and Ala-11 cystatin C variants displayed Ki values for the two endopeptidases that were approx. 20-fold higher than those of wild-type cystatin C, while the corresponding values for the Trp-11. Arg-11 and Glu-11 variants were increased by a factor of about 2000. In contrast, the Ki values for the interactions of all five variants with the exopeptidase differed from that of wild-type cystatin C by a factor of less than 10. Wild-type cystatin C and the Ser-11, Ala-11 and Glu-11 variants were incubated with neutrophil elastase, which in all cases resulted in the rapid hydrolysis of a single peptide bond, between amino acid residues 10 and 11. The Ki values for the interactions with papain of these three N-terminal-decapeptide-lacking cystatin C variants were 20-50 nM, just one order of magnitude higher than the value for N-terminally truncated wild-type cystatin C, which in turn was similar to the corresponding values for the full-length Glu-11, Arg-11 and Trp-11 variants. These data indicate that the crucial feature of the conserved Gly residue in position 11 of wild-type cystatin C is that this residue, devoid of a side-chain, will allow the N-terminal segment of cystatin C to adopt a conformation suitable for interaction with the substrate-binding pockets of cysteine endopeptidases, resulting in high-affinity binding and efficient inhibition. The functional properties of the remaining part of the proteinase contact area, which is built from more C-terminal inhibitor segments, are not significantly affected even when amino acids with bulky or charged side-chains replace the Gly-11 residue of the N-terminal segment.

Citing Articles

Heterologous Production and Evaluation of the Biological Activity of Cystatin-B From the Red Piranha .

Merlano J, Almeida D Front Genet. 2022; 13:812971.

PMID: 35719393 PMC: 9203827. DOI: 10.3389/fgene.2022.812971.

Macrophage immunomodulation in chronic osteolytic diseases-the case of periodontitis.

Sima C, Viniegra A, Glogauer M J Leukoc Biol. 2018; 105(3):473-487.

PMID: 30452781 PMC: 6386606. DOI: 10.1002/JLB.1RU0818-310R.

Journey of cystatins from being mere thiol protease inhibitors to at heart of many pathological conditions.

Shamsi A, Bano B Int J Biol Macromol. 2017; 102:674-693.

PMID: 28445699 PMC: 7112400. DOI: 10.1016/j.ijbiomac.2017.04.071.

Identification of cystatin SA as a novel inhibitor of acid ceramidase.

Eliyahu E, Shtraizent N, He X, Chen D, Shalgi R, Schuchman E J Biol Chem. 2011; 286(41):35624-35633.

PMID: 21846728 PMC: 3195560. DOI: 10.1074/jbc.M111.260372.

The crystal structures of two salivary cystatins from the tick Ixodes scapularis and the effect of these inhibitors on the establishment of Borrelia burgdorferi infection in a murine model.

Kotsyfakis M, Horka H, Salat J, Andersen J Mol Microbiol. 2010; 77(2):456-70.

PMID: 20545851 PMC: 2909360. DOI: 10.1111/j.1365-2958.2010.07220.x.

References

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Hall A, Abrahamson M, Grubb A, Trojnar J, Kania P, Kasprzykowska R . Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: influence of the peptidyl chain length. J Enzyme Inhib. 1992; 6(2):113-23. DOI: 10.3109/14756369209040742. View

Henderson P . A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors. Biochem J. 1972; 127(2):321-33. PMC: 1178592. DOI: 10.1042/bj1270321. View

Tonnelle C, Colle A, Fougereau M, MANUEL Y . Partial amino acid sequence of two forms of human post-gamma-globulin. Biochem Biophys Res Commun. 1979; 86(3):613-9. DOI: 10.1016/0006-291x(79)91757-1. View

JEPPSSON J, LAURELL C, Franzen B . Agarose gel electrophoresis. Clin Chem. 1979; 25(4):629-38. View

Gauthier F, Fryksmark U, Ohlsson K, Bieth J . Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitor. Biochim Biophys Acta. 1982; 700(2):178-83. DOI: 10.1016/0167-4838(82)90095-4. View

Barrett A, Kembhavi A, Brown M, KIRSCHKE H, Knight C, Tamai M . L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J. 1982; 201(1):189-98. PMC: 1163625. DOI: 10.1042/bj2010189. View

Grubb A, Lofberg H . Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci U S A. 1982; 79(9):3024-7. PMC: 346341. DOI: 10.1073/pnas.79.9.3024. View

Zoller M, Smith M . Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA. Nucleic Acids Res. 1982; 10(20):6487-500. PMC: 326938. DOI: 10.1093/nar/10.20.6487. View

10.

Barrett A, Davies M, Grubb A . The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun. 1984; 120(2):631-6. DOI: 10.1016/0006-291x(84)91302-0. View

11.

GOUNARIS A, Brown M, Barrett A . Human plasma alpha-cysteine proteinase inhibitor. Purification by affinity chromatography, characterization and isolation of an active fragment. Biochem J. 1984; 221(2):445-52. PMC: 1144057. DOI: 10.1042/bj2210445. View

12.

Nicklin M, Barrett A . Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin. Biochem J. 1984; 223(1):245-53. PMC: 1144286. DOI: 10.1042/bj2230245. View

13.

Wakamatsu N, Kominami E, Takio K, Katunuma N . Three forms of thiol proteinase inhibitor from rat liver formed depending on the oxidation-reduction state of a sulfhydryl group. J Biol Chem. 1984; 259(22):13832-8. View

14.

Takeda A, Kaji H, Nakaya K, Aoki Y, Nakamura Y, Samejima T . Amino acid sequence of derivatives of newborn rat epidermal thiol proteinase inhibitor. Biochem Int. 1985; 11(4):557-64. View

15.

Abrahamson M, Barrett A, Salvesen G, Grubb A . Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem. 1986; 261(24):11282-9. View

16.

Barrett A, Fritz H, Grubb A, Isemura S, Jarvinen M, Katunuma N . Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochem J. 1986; 236(1):312. PMC: 1146824. DOI: 10.1042/bj2360312. View

17.

Abrahamson M, Grubb A, Olafsson I, Lundwall A . Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett. 1987; 216(2):229-33. DOI: 10.1016/0014-5793(87)80695-6. View

18.

Abrahamson M, Ritonja A, Brown M, Grubb A, Machleidt W, Barrett A . Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. J Biol Chem. 1987; 262(20):9688-94. View

19.

Schagger H, von Jagow G . Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 1987; 166(2):368-79. DOI: 10.1016/0003-2697(87)90587-2. View

20.

Abrahamson M, Dalboge H, Olafsson I, Carlsen S, Grubb A . Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS Lett. 1988; 236(1):14-8. DOI: 10.1016/0014-5793(88)80276-x. View